Knee pain is often a result of articular cartilage defects. These defects do not heal on their own and require adequate treatment.
Experience the breakthrough in cartilage regeneration. Scientifically proven and designed for lasting results.
Is knee pain limiting your daily activities?
RECARTA is a patient-specific, biological, and regenerative cartilage cell therapy for knee cartilage damage.
RECARTA helps to regenerate cartilage tissue, protect the joint, reduce pain, improve function, and deliver lasting results.
See if you are eligible for the procedure.
Reference: 1. Brittberg M, Recker D, Ilgenfritz J, Saris D. SUMMIT Extension Study Group. Matrix-applied characterized autologous cultured chondrocytes versus microfracture: Five-year follow-up of a prospective randomized trial. Am J Sports Med. 2018; 2. Ebert JR, Robertson WB, Woodhouse J, Fallon M, Zheng MH, Ackland T, Wood DJ. Clinical and magnetic resonance imaging-based outcomes to 5 years after matrix-induced autologous chondrocyte implantation to address articular cartilage defects in the knee. Am J Sports Med. 2011. 3. Marlovits, S., et al. Clinical and Radiological Outcomes 5 Years after Matrix-Induced Autologous Chondrocyte Implantation in Patients with Symptomatic, Traumatic Chondral Defects. Am J Sports Med. 2011. 4. Gille J, Behrens P, Schulz AP, Oheim R, Kienast B. Matrix-Associated Autologous Chondrocyte Implantation: A Clinical Follow-Up at 15 Years. Cartilage. 2016
©2024 Keli Therapeutics. All Rights Reserved.
Address
Sukileliu ave. 15
LT-50162 Kaunas
Contacts
+370 690 22777
info@keli.eu
